These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6407375)

  • 41. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition.
    Izsak EM; Shike M; Roulet M; Jeejeebhoy KN
    Gastroenterology; 1980 Sep; 79(3):555-8. PubMed ID: 6776004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.
    Smith AJ; Faugère MC; Abreo K; Fanti P; Julian B; Malluche HH
    Am J Nephrol; 1986; 6(4):275-83. PubMed ID: 3777036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High bone turnover associated with an aluminum-induced impairment of bone mineralization.
    Charhon SA; Chavassieux PM; Chapuy MC; Traeger J; Meunier PJ
    Bone; 1986; 7(5):319-24. PubMed ID: 3790372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB; Alfrey AC; Miller NL; Goodman WG
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 48. A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams.
    Villanueva AR; Lundin KD
    Stain Technol; 1989 May; 64(3):129-38. PubMed ID: 2480003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aluminum in parenteral solutions revisited--again.
    Klein GL
    Am J Clin Nutr; 1995 Mar; 61(3):449-56. PubMed ID: 7872206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total parenteral nutrition and its effects on bone metabolism.
    Klein GL; Coburn JW
    Crit Rev Clin Lab Sci; 1994; 31(2):135-67. PubMed ID: 7917007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive bone loss during long-term home total parenteral nutrition.
    Foldes J; Rimon B; Muggia-Sullam M; Gimmon Z; Leichter I; Steinberg R; Menczel J; Freund HR
    JPEN J Parenter Enteral Nutr; 1990; 14(2):139-42. PubMed ID: 2112620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic bone disease in a patient on long-term total parenteral nutrition: a case report with review of literature.
    Seligman JV; Basi SS; Deitel M; Bayley TA; Khanna RK
    JPEN J Parenter Enteral Nutr; 1984; 8(6):722-7. PubMed ID: 6441020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
    Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
    Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A longitudinal study of calcium regulation in a nonhuman primate model of parenteral nutrition.
    Lipkin EW
    Am J Clin Nutr; 1998 Feb; 67(2):246-54. PubMed ID: 9459372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aluminum deposition in the bone of patients with chronic renal failure--detection of aluminum accumulation without signs of aluminum toxicity in bone using acid solochrome azurine.
    Rüster M; Abendroth K; Lehmann G; Stein G
    Clin Nephrol; 2002 Oct; 58(4):305-12. PubMed ID: 12400847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excessive aluminum accumulation in the bones of patients on long-term parenteral nutrition: postmortem analysis by electrothermal atomic absorption spectrometry.
    Kruger PC; Parsons PJ; Galusha AL; Morrissette M; Recker RR; Howard LJ
    JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):728-35. PubMed ID: 23765064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.
    Milliner DS; Nebeker HG; Ott SM; Andress DL; Sherrard DJ; Alfrey AC; Slatopolsky EA; Coburn JW
    Ann Intern Med; 1984 Dec; 101(6):775-9. PubMed ID: 6208838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between serum albumin and parenteral nutrition-associated cholestasis.
    Nanji AA; Anderson FH
    JPEN J Parenter Enteral Nutr; 1984; 8(4):438-9. PubMed ID: 6431134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic bone disease associated with total parenteral nutrition.
    Buchman AL; Moukarzel A
    Clin Nutr; 2000 Aug; 19(4):217-31. PubMed ID: 10952792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.